Cleveland, Ohio; and Tampa, Fla. From Case Western Reserve University School of Medicine; the Department of Surgery, MetroHealth Medical Center; the Department of Plastic Surgery, University Hospitals Case Medical Center; and the Department of Surgery, University of South Florida.
Plast Reconstr Surg. 2012 Dec;130(6):799e-809e. doi: 10.1097/PRS.0b013e31826d9cb0.
Müller's muscle-conjunctival resection is used to correct mild to moderate ptosis commonly encountered in the rejuvenation patient population. The authors examined its efficacy and analyzed variables that potentially affect outcomes.
Patients who underwent ptosis correction using Müller's muscle-conjunctival resection with greater than 10-month follow-up were included. Amount of ptosis reduction, eyelid symmetry, effects of concomitant facial aesthetic operations, and adverse outcomes were analyzed. Patients were grouped into medium- (<24 months after surgery) and long-term follow-up (>24 months) cohorts to determine whether outcomes changed over time.
Forty patients with a mean follow-up of 28 months combined for a total of 70 resection operations. Resection significantly reduced ptosis by a mean of 1.48 ± 0.88 mm (p < 0.001), corresponding to 0.19 mm of eyelid elevation for every 1.0 mm of Müller's muscle resected. The procedure successfully corrected 84 percent of eyelids to within 0.5 mm and 94 percent to within 1.0 mm of normal eyelid position. On patients with asymmetric ptosis, it significantly improved eyelid symmetry to within 1.0 mm from 85 percent of patients before surgery to 95 percent after surgery, and to within 0.5 mm from 53 percent before surgery to 75 percent of patients after surgery (p = 0.036). Furthermore, the mean correction of ptosis was not significantly different between medium- (1.58 ± 0.93 mm) and long-term (1.32 ± 0.93 mm) follow-up patients (p = 0.258).
Müller's muscle-conjunctival resection is an effective long-term solution to mild to moderate eyelid ptosis and asymmetry, and can be effectively performed concomitantly with other aesthetic facial procedures.
CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, IV.
Müller 肌-结膜切除术常用于矫正年轻化患者群体中常见的轻度至中度上睑下垂。作者检查了其疗效,并分析了可能影响结果的变量。
纳入了接受 Müller 肌-结膜切除术矫正上睑下垂且随访时间超过 10 个月的患者。分析了上睑下垂的减轻量、眼睑对称性、伴随的面部美容手术的影响以及不良结果。患者被分为中期(术后<24 个月)和长期(>24 个月)随访组,以确定结果是否随时间变化。
40 例患者平均随访 28 个月,共进行了 70 次切除术。切除术平均减少了 1.48±0.88mm 的上睑下垂(p<0.001),相当于每切除 1.0mm 的 Müller 肌,上睑抬高 0.19mm。该手术成功将 84%的眼睑矫正至距正常眼睑位置 0.5mm 以内,94%的眼睑矫正至 1.0mm 以内。对于患有不对称性上睑下垂的患者,它将眼睑对称性从术前的 85%显著改善至术后的 95%,并从术前的 53%显著改善至术后的 75%,且均在 0.5mm 以内(p=0.036)。此外,中期(1.58±0.93mm)和长期(1.32±0.93mm)随访患者之间的上睑下垂平均矫正程度无显著差异(p=0.258)。
Müller 肌-结膜切除术是矫正轻度至中度眼睑下垂和不对称的有效长期解决方案,并且可以与其他美容面部手术有效同时进行。
临床问题/证据水平:治疗,IV。